May 27, 2022 Lytix Biopharma to present Adoptive Cell Therapy at ASCO 2022 OSLO: Lytix Biopharma AS, a clinical-stage company with an in situ vaccination technology platform, announces that an abstract relating to LTX-315 in combination with…